These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4135410)

  • 21. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 22. Juxtaglomerular index, plasma renin, and erythropoietin in canine renal allografts.
    Varkarakis MJ; Sampson D; Mirand EA; Murphy GP
    Invest Urol; 1972 Mar; 9(5):394-400. PubMed ID: 4552603
    [No Abstract]   [Full Text] [Related]  

  • 23. Preliminary results with passive enhancement in human kidney transplantation.
    Solheim BG; Flatmark A; Thorsby E
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive enhancement of kidney allografts: potentiation with antithymocyte serum.
    Batchelor JR; Fabre J; Morris PJ
    Transplantation; 1972 Jun; 13(6):610-3. PubMed ID: 4556073
    [No Abstract]   [Full Text] [Related]  

  • 25. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
    Holter AR; Neu MR; McKearn TJ; Lynch AF; Stuart FP
    Transplant Proc; 1973 Mar; 5(1):593-6. PubMed ID: 4121180
    [No Abstract]   [Full Text] [Related]  

  • 26. Antilymphocyte globulin prepared by precipitation with Rivanol in the treatment of acute rejection following allogenic renal transplantation in the dog.
    Husberg B; Carlsson S; Hellsten S; Liedberg CF; Nettelblad SC; Weiber A
    Scand J Urol Nephrol; 1972; 6(2):154-6. PubMed ID: 4557339
    [No Abstract]   [Full Text] [Related]  

  • 27. Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
    Wilson RE; Garovoy MR; Strom TB; Lowry RP; Busch GJ; Vineyard GC; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):531-2. PubMed ID: 7022888
    [No Abstract]   [Full Text] [Related]  

  • 28. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment.
    Corman JL; Kashiwagi N; Porter KA; Andres G; Iwatsuki S; Putnam CW; Popovtzer M; Penn I; Starzl TE
    Transplantation; 1973 Jul; 16(1):60-3. PubMed ID: 4576857
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolonged renal allograft survival associated with antigen pretreatment.
    Wilson RE; Rippen A; Hayes CR; Dagher RK; Busch GJ
    Transplant Proc; 1969 Mar; 1(1):290-2. PubMed ID: 4944229
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
    Kountz SL; Rao TK; Butt KH
    Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal transplantation in the rabbit. I. Development of a model for study of hyperacute rejection and immunological enhancement.
    Holter AR; McKearn TJ; Neu MR; Fitch FW; Stuart FP
    Transplantation; 1972 Mar; 13(3):244-9. PubMed ID: 4112148
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of humoral rejection of renal allografts in presensitized monkeys by monospecific F(ab')2 fragments.
    Kahan MG; Martins AC; Macpherson SG; Wren SF; Busch GJ; Wilson RE
    Surg Forum; 1975; 26():311-3. PubMed ID: 814638
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of medroxyprogesterone and corticosteroids in the treatment of canine renal allografts.
    Macdonald AS; Falvey CF; Chan CC
    Can J Surg; 1972 Sep; 15(5):326-31. PubMed ID: 4560407
    [No Abstract]   [Full Text] [Related]  

  • 34. Rejection crises in human renal transplant recipients: control with high dose methylprednisolone therapy.
    Turcotte JG; Feduska NJ; Carpenter EW; McDonald FD; Bacon GE
    Arch Surg; 1972 Aug; 105(2):230-6. PubMed ID: 4557979
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunologic injury induced by ex vivo perfusion of canine renal autografts.
    Filo RS; Dickson LG; Suba EA; Sell KW
    Surgery; 1974 Jul; 76(1):88-100. PubMed ID: 4601595
    [No Abstract]   [Full Text] [Related]  

  • 36. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG.
    Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG
    Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275
    [No Abstract]   [Full Text] [Related]  

  • 37. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

  • 39. Corticosteroids in immunosuppression: partial fulfillment of a promise.
    Friedman EA
    Transplant Proc; 1975 Mar; 7(1):1-3. PubMed ID: 164066
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of renal allograft rejection. Instances in dogs with specific enchancing immunoglobulin and its proteolytic fragments.
    Yonemoto RH; Deliman RM; DuSold WD; Hamilton T
    Arch Surg; 1973 Sep; 107(3):390-4. PubMed ID: 4593193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.